Clofarabine plus cytarabine (ara-C) is an active induction regimen for newly diagnosed patients (pts) ≥ age 50 with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: S. Faderl, V. Gandhi, F. Giles, E. Estey, G. Garcia-Manero, S. O Brien, W. Wierda, M. Kwari, A. Craig, H. M. Kantarjian
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2338246439